Zhanxuan E. Wu

机构：Sichuan University, Frontier Hospital

发表论文 10 篇 · 总被引 212 次 · h-index 7

代表论文

• Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery (2023 · Journal of Controlled Release · 被引 56)
• Recent advances in metabolism and toxicity of tyrosine kinase inhibitors (2022 · Pharmacology & Therapeutics · 被引 56)
• Metabolomics Reveals Gut Microbiota Contribute to PPARα Deficiency-Induced Alcoholic Liver Injury (2023 · Journal of Proteome Research · 被引 25)
• Metabolomic signatures for visceral adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study (2020 · Nutrition & Metabolism · 被引 21)
• Celastrol as an intestinal FXR inhibitor triggers tripolide-induced intestinal bleeding: Underlying mechanism of gastrointestinal injury induced by Tripterygium wilfordii (2023 · Phytomedicine · 被引 20)
• Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol (2022 · Molecules · 被引 10)